Pacira BioSciences (PCRX)
24.68
0.00 (0.00%)
Upcoming Events
Latest Headlines
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 9, 2026 8:00 AM - StreetInsider
Leerink Starts Pacira Pharmaceuticals (PCRX) at Market Perform
September 9, 2026 6:10 AM - StreetInsider
PharmaCorp Rx Inc. Announces Board and Committee Changes
August 27, 2026 7:30 AM - Globe NewsWire
PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results
August 20, 2026 7:30 AM - Globe NewsWire
Form 4 Pacira BioSciences, Inc. For: Aug 17 Filed by: SLONIN JONATHAN
August 18, 2026 5:21 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: SLONIN JONATHAN
August 17, 2026 11:54 AM - SEC Filing
Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
August 17, 2026 6:14 AM - StreetInsider
Form SCHEDULE 13G Pacira BioSciences, Inc. Filed by: STATE STREET CORP
August 7, 2026 10:33 AM - SEC Filing
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 8:00 AM - StreetInsider
Pacira publishes two-year Phase 1 data for knee OA gene therapy
August 6, 2026 8:00 AM - StreetInsider
Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
August 6, 2026 8:00 AM - StreetInsider
Pacira Pharmaceuticals (PCRX) PT Raised to $25 at RBC Capital
August 5, 2026 7:49 AM - StreetInsider
Pacira Pharma (PCRX) Tops Q2 EPS by 8c ; Offers Guidance
August 5, 2026 12:41 AM - StreetInsider
Form S-8 Pacira BioSciences, Inc.
August 4, 2026 5:11 PM - SEC Filing
Form 10-Q Pacira BioSciences, Inc. For: Jun 30
August 4, 2026 4:32 PM - SEC Filing
Form 8-K Pacira BioSciences, Inc. For: Aug 04
August 4, 2026 4:04 PM - SEC Filing
Pacira BioSciences Reports Second Quarter 2026 Financial Results
August 4, 2026 4:01 PM - StreetInsider
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
July 28, 2026 8:00 AM - StreetInsider
Pacira enrolls first patient in PCRX-201 Phase 2 study Part B
July 27, 2026 8:04 AM - StreetInsider
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
July 27, 2026 8:00 AM - StreetInsider
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
July 22, 2026 8:00 AM - StreetInsider
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 8, 2026 8:00 AM - StreetInsider
PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update
July 6, 2026 7:30 AM - Globe NewsWire
UnitedHealthcare to separately reimburse Pacira's EXPAREL drug
July 1, 2026 8:01 AM - StreetInsider
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
July 1, 2026 8:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Pacira Pharmaceuticals (PCRX)
July 1, 2026 6:59 AM - StreetInsider
Form 8-K Pacira BioSciences, Inc. For: Jun 28
June 30, 2026 7:32 AM - SEC Filing
Pacira BioSciences to sell iovera° unit to Zimmer Biomet for up to $140M
June 30, 2026 7:31 AM - StreetInsider
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
June 30, 2026 7:30 AM - StreetInsider
Full Article List
